Companies

Kyverna Therapeutics, Inc. (KYTX) SEC filings

CIK 0001994702 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Net income (USD)-161.3 M-60.4 M
Diluted EPS (USD/shares)-3.64-89.61

Latest filings

FiledFormDescriptionPeriod
2026-10-19SCHEDULE 13GSCHEDULE 13G
2026-09-248-K8-K items 7.01,9.012026-09-24
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,9.012026-08-11
2026-07-29SCHEDULE 13GSCHEDULE 13G
2026-07-278-K8-K items 1.01,7.01,9.012026-07-23
2026-07-098-K8-K items 1.01,9.012026-07-08
2026-06-028-K8-K items 5.07,9.012026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-29442026-05-27
2026-05-20442026-05-18
2026-05-20332026-05-18
2026-05-188-K8-K items 5.02,8.01,9.012026-05-14
2026-05-1210-Q10-Q2026-03-31
2026-05-128-K8-K items 2.02,9.012026-05-12
2026-05-06442026-05-04
2026-05-06332026-05-04
2026-05-048-K8-K items 8.01,9.012026-05-04
2026-04-228-K8-K items 7.01,9.012026-04-22
2026-04-228-K8-K items 7.01,9.012026-04-21
2026-04-208-K8-K items 7.01,9.012026-04-20

Forms on file (last 1,000): 4 41, 8-K 41, 3 27, 10-Q 8, UPLOAD 7, CORRESP 6, 144 5, SC 13G 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=KYTX (0.002 USD), /gw/filings/filings?ticker=KYTX&form=8-K, /gw/filings/facts?ticker=KYTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange